NHS England now offers first drug improving multiple sclerosis patients' walking
Around 5,000 individuals in England stand to gain annually from fampridine, a multiple sclerosis drug described as a "signal booster". Fampridine improves nerve signals, making it easier for some patients to move and live independently. Clinical trials showed about four in ten people taking the drug had better walking speed and could walk for longer.
Lost in this story? That's the point of BriefTea.
Open it in the app and tap Learn from this — the Knowledge Galaxy turns the story into a map of everything it assumes you know, one tap at a time. Free, no ads, no paywall.
Get BriefTea on the App Store